Protein kinase A inhibitors reverse histamine-mediated regulation of IL- 5 secretion

Immunopharmacology

Volumn 39, Issue 1, 1998, Pages 9-19

  Poluektova, Larisa Y ^a   Khan, Manzoor M ^a  

^a CREIGHTON UNIVERSITY   (United States)

Author keywords

D10.G4.1 mouse Th2 helper cells; H 8; Histamine; Interleukin 5; Protein kinase A; Rp cAMPS

Indexed keywords

BUCLADESINE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC AMP DERIVATIVE; FORSKOLIN; HISTAMINE; INTERLEUKIN 5; N (2 METHYLAMINOETHYL) 5 ISOQUINOLINESULFONAMIDE;

ALLERGY; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HELPER CELL; IMMUNOMODULATION; IMMUNOPHARMACOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION;

ANIMALS; BUCLADESINE; CELL LINE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FORSKOLIN; HISTAMINE; HISTAMINE RELEASE; INTERLEUKIN-5; ISOQUINOLINES; MICE; T-LYMPHOCYTES, HELPER-INDUCER; THIONUCLEOTIDES;

EID: 0031810595     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(97)00093-3     Document Type: Article

References (42)

1. Anastassiou E.D., Paliogianni F., Balow J.P., Yamado H., Boumpas D.T. Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2Ra gene expression at multiple levels. J. Immunol. 141(9):1992;2845-2852.
2. Averill L.E., Stein R.L., Kammer G.M. Control of human T-lymphocyte interleukin-2 production by a c-AMP-dependent pathway. Cell. Immunol. 115:1988;88-99.
3. Beer D.J., Rocklin R.E. Histamine modulation of lymphocyte biology: Membrane receptors, signal transduction, and functions. Crit. Rev. Immunol. 7(1):1987;55-91.
4. Botelho L.H.P., Rothermel J.D., Coombs R.B., Jastorff B. cAMP analog antagonists of cAMP action. Methods Enzymol. 159:1988;159-172.
5. Dohlsten M., Sjogren H.O., Carlsson R. Histamine acts directly on human T cells to inhibit interleukin-2 and interferon-γ production. Cell. Immunol. 109(1):1987;65-74.
6. Enokihava H., Nakamura Y., Nagashima S., Furusawa S., Shishido H. Regulation of interleukin-5 production by interleukin-4, interferon-α, transforming growth factor-beta and interleukin-6. Int. Arch. Allergy Immunol. 104 (suppl.):1994;44-45.
7. Gavett S.H., O'Hearn D.J., Li X., Huang S.K., Finkelman F.D., Wills-Karp M. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. 182(5):1995;1527-1536.
8. Graves J.D., Cantell D.A. An analysis of the role of guanine nucleotide binding proteins in antigen receptor/CD3 antigen coupling to phospholipase C. J. Immunol. 146(7):1991;2102-2107.
9. Harris J.N., Hutchinson I.V. A novel fluorescein-histamine reagent to quantitative histamine receptor expression on leukocytes. Int. J. Immunopharmacol. 16(8):1994;633-640.
10. Hidaka H., Inagaki M., Kawamoto S., Sasaki Y. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry. 23(21):1984;5036-5041.
11. Kammer G.M. The adenylate cyclase cAMP-protein kinase. A pathway and regulation of the immune response. Immunol. Today. 8:1988;222-229.
12. Khan M. Regulation of IL-4 and IL-5 secretion by histamine and PGE2. Adv. Exp. Med. Biol. 383:1995;35-42.
13. Khan M.M., Melmon K.L., Fathman C.G., Hertel-Wulff B., Strober S. The effects of autacoids on cloned murine lymphoid cells: Modulation of IL-2 secretion and the activity of natural suppressor cells. J. Immunol. 134:1985;4100-4106.
14. 4+ T cells while decreasing IL-2 release and NF-AT induction. Int. Immunol. 6(9):1994;1333-1343.
15. Laximinarayana D., Kammer G.M. Activation of type I protein kinase during receptor-mediated human T lymphocyte activation. J. Immunol. 156:1996;497-506.
16. Lee H.J., Koyano-Nakagawa N., Naito Y., Nishida J., Arai N., Arai K., Yokota T. cAMP activates the ester through the signaling pathway involving protein kinase A in mouse thymoma line EL-4. J. Immunol. 151(11):1993;6135-6142.
17. Lee H.J., Matsuda I., Naito Y., Takashi Y., Arai N., Arai K. Signals and nuclear factors that regulate the expression of interleukin-4 and interleukin-5 genes in helper T cells. J. Allergy Clin. Immunol. 94(3, p.2):1994;594-604.
18. Limaye A.P., Abrams J.S., Silver J.E., Ottesen E.A., Nutman T.B. Regulation of parasite-induced eosinophilia: Selectively increase interleukin-5 production in helmint-infected patients. J. Exp. Med. 172(1):1990;399-402.
19. Lohmann S.M., Walter U. Regulation of the cellular and subcellular concentrations and distribution of cyclic nucleotide-dependent protein kinases. Adv. Cyclic Nucleotide Protein Phosphorylation Res. 18:1984;63-117.
20. Macdonald D., Gordon A.A., Kajitani H., Enokihara H., Barrett A.J. Interleukin-2 treatment-associated eosinophilia is mediated by interleukin-5 production. Br. J. Heamatol. 76(2):1990;168-173.
21. Mary D., Aussel C., Ferrula B., Fehlmann M. Regulation of interleukin-2 synthesis by cAMP in human T cells. J. Immunol. 139(4):1987;1179-1184.
22. Munoz E., Zubiaga A.M., Merrow M., Sauter N., Huber B.T. Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediate activation: Role of cAMP in T cell proliferation. J. Exp. Med. 172(1):1990;95-103.
23. Munoz E., Zubiaga A.M., Munoz J., Huber B.T. Regulation of IL-4 lymphokine gene expression and cellular proliferation in murine T helper type II cells. Cell Regulation. 1(5):1990;425-434.
24. Naora H., Young I.G. Comparison of the mechanisms regulation IL-5, IL-4 and three other lymphokine genes in the Th2 clone D10.G4.1. Exp. Hematol. 23(7):1995;597-602.
25. Naora H., Altin J.G., Young I.G. TCR-dependent and -independent signaling mechanisms differentially regulate lymphokine gene expression in murine T helper clone D10.G4.1. J. Immunol. 152(12):1994;5692-5702.
26. Novak T.J., Rothenberg E.V. cAMP inhibits induction of interleukin-2 but not of interleukin-4 in T cells. Proc. Natl. Acad. Sci. USA. 87:1990;9353-9357.
27. Rezai A.R., Salazar-Gonzalez J.F., Martinez-Maza O., Bramhall J.B., Afrasiabi R., Kermani-Arab V. Histamine blocks interleukin-2 (IL-2) gene expression and regulates IL-2 receptor expression. Immunopharm. Immunotoxic. 12(3):1990;345-362.
28. Robinson D.S., Durham S.R., Kay A.B. Cytokines. 3. Cytokines in asthma. Thorax. 48(8):1993;845-853.
29. Romagnani S. Human TH1 and TH2 subsets: Regulation of differentiation and role in protection and immunopathology. Int. Arch. Allergy Immunol. 98(4):1992;279-285.
30. Sanderson C.J. Interleukin-5 eosinophils, and disease. Blood. 79(12):1992;3101-3109.
31. Sansoni P., Silverman E.D., Khan M.M., Melmon K.L., Engleman E.G. Immunoregulatory T cells in man: Histamine-induced suppressor T cells are derived from a Leu 2+(T8+) subpopulation distinct from that which gives rise to cytotoxic T cells. J. Clin. Invest. 75:1985;650-656.
32. 4+ T cells. J. Clin. Invest. 97(2):1996;309-315.
33. Schmidt J., Fleibner S., Heimann-Weitschat I., Lindstaedt R., Szelenyi I. Histamine increases anti-CD3 induced IL-5 production of Th2-type T cells via histamine H2-receptors. Agents Actions. 42(3)(4):1994;81-85.
34. Snjidewint F.G.M., Kalinski P., Wierenga E.A., Bos J.D., Kapsenberg M.L. ProstaglandinE2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J. Immunol. 150(12):1993;5321-5329.
35. Tsuruta L., Lee H.J., Masuda E.S., Yokota T., Arai N., Arai K. Regulation of expression of the IL-2 and IL-5 genes and the role of proteins related to nuclear factor of activated T cells. J. Allergy Clin. Immunol. 96(6 Pt 2):1995;1126-1135.
36. 4+ allergen-specific T lymphocytes in atopic dermatitis lesional skin. J. Invest. Dermatol. 97(3):1991;389-394.
37. Van der Pouw-Kraan T., Van Kooten C., Rensink I., Aarden L. Interleukin (IL)-4 production by human T cells: Differential regulation of IL-4 vs. IL-2 production. Eur. J. Immunol. 22(5):1992;1237-1241.
38. Warlow R.S., Rajasekariah P., Lambert P., Morgan J., Dao L.P., Bernard C.C.A., Walls R.S. Purification of histamine receptor proteins from detergent-solubilized human peripheral blood mononuclear cells. Biochemistry. 33(16):1994;4800-4811.
39. Warren H.S., Kinnear B.F., Phillips J.H., Lanier L.L. Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10 and IL-12. J. Immunol. 154(10):1995;5144-5152.
40. Wierenga E.A., Backx B., Snoek M., Koenderman L., Kapsenberg M.L. Relative contributions of human types 1 and 2 T-helper cell-derived eosinophilotrophic cytokines to development of eosinophilia. Blood. 82(5):1993;1471-1479.
41. Yoshimasa T., Sibley D.R., Bouvier M., Lefkowitz R.J., Caron M.G. Cross-talk between cellular signaling pathways suggested by phorbol-ester induced adenylate cyclase phosphorylation. Nature. 327(6117):1987;67-70.
42. Yousefi S., Hoessli D.C., Blaser K., Mills G.B., Simon H.U. Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils. J. Exp. Med. 183(4):1996;1407-1414.